Market Overview:
The global antiretroviral therapy market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of HIV/AIDS, rising demand for better treatment options, and technological advancements in the field of antiretroviral therapy. Based on type, the global antiretroviral therapy market is segmented into NNRTIs, NRTIs, multiclass combination products, and integrase inhibitors. The NNRTI segment is expected to account for the largest share of the global antiretroviral therapy market in 2018. This can be attributed to factors such as their high efficacy and safety profile coupled with low pill burden. Based on application, the hospital segment is expected to account for the largest share of the global antiretroviral therapy market in 2018.
Product Definition:
Antiretroviral therapy (ART) is a combination of medications used to treat HIV infection. ART prevents the virus from multiplying, which lowers the amount of virus in the body. This helps keep HIV from damaging the immune system and keeps CD4 cell counts high.
NNRTIs:
NNRTIs are Non-nucleoside Reverse Transcriptase Inhibitors. They are a type of Antiretroviral drug used to treat HIV infection. NNRTIs differ from nucleoside reverse transcriptase inhibitors in that they lack the ability to inhibit reverse transcriptase activity directly; instead, they target cellular proteins involved in the regulation of gene expression.
NRTI:
NRTIs are a class of Antiretroviral Drugs that inhibit the reverse transcriptase enzyme. The inhibition of this enzyme results in reduced viral replication. Some NRTIs also have the ability to prevent early steps of reverse transcription, thus preventing viral gene synthesis and activity.
Application Insights:
The other application segment held the largest share of over 70.0% in 2017. This is due to the growing usage of antiretroviral therapy for treating chronic diseases, such as hepatitis C and B, which are highly prevalent in several countries across Asia Pacific and Central & South America. In addition, increasing research & development activities by major players for developing new products with better efficacy and fewer side effects will boost market growth over the forecast period.
Clinic-based settings accounted for a significant share owing to rising awareness about availability of effective treatment options along with low cost access to these drugs; this factor has led to an increase in HIV infections among adults through sexual intercourse or intravenous drug use., The hospital-based setting was estimated as the largest application segment owing to high prevalence levels that have not been effectively treated despite widespread availability of antiretroviral therapy at affordable prices.
Regional Analysis:
The global antiretroviral therapy market is dominated by North America owing to the presence of key players, high patient awareness levels and availability of a wide range of drugs. The U.S. accounted for the largest revenue share in 2016 and is anticipated to maintain its dominance over the forecast period due to increasing prevalence of HIV/AIDS, growing treatment accessions, rising healthcare expenditure and supportive government initiatives pertaining towards treatment accession assistance programs (TAA).
Asia Pacific region is expected to grow at a lucrative rate during the forecast period owing to improving economic conditions in emerging countries such as India & China along with other factors such as low cost base for manufacturing antiretrovirals that are expected drive regional growth during the forecast period. Moreover, growing demand for generic drugs from low-income countries will further propel growth over coming years.
Growth Factors:
- Increasing incidence of HIV/AIDS: The global incidence of HIV is on the rise, with an estimated 36.7 million people living with the virus in 2016. This is expected to drive demand for antiretroviral therapies in the coming years.
- Growing awareness about HIV and its treatment: There is a growing awareness among people about HIV and its treatment options, which is likely to boost demand for antiretroviral therapies in the near future.
- Technological advancements: The development of new and more effective antiretroviral therapies has helped to improve patient outcomes, thus driving market growth.
- Rising healthcare expenditure: There has been a significant increase in healthcare spending across developed and developing countries over the past few years, which is likely to spur demand for antiretroviral therapies in the coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Antiretroviral Therapy Market Research Report
By Type
NNRTIs, NRTI, Multiclass Combination Products, Integrase Inhibitors
By Application
Hospital, Clinic, Other
By Companies
Gilead, F. Hoffmann-La Roche, ViiV Healthcare, Boehringer Ingelheim, Janssen Pharmaceuticals, Mylan, Abbvie, Bionor Pharma, Vertex Pharmaceuticals, Gilead
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Antiretroviral Therapy Market Report Segments:
The global Antiretroviral Therapy market is segmented on the basis of:
Types
NNRTIs, NRTI, Multiclass Combination Products, Integrase Inhibitors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Gilead
- F. Hoffmann-La Roche
- ViiV Healthcare
- Boehringer Ingelheim
- Janssen Pharmaceuticals
- Mylan
- Abbvie
- Bionor Pharma
- Vertex Pharmaceuticals
- Gilead
Highlights of The Antiretroviral Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- NNRTIs
- NRTI
- Multiclass Combination Products
- Integrase Inhibitors
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antiretroviral Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antiretroviral therapy (ART) is a combination of medications that helps to prevent the spread of HIV. ART includes three main classes: antiretroviral drugs, protease inhibitors, and nucleoside reverse transcriptase inhibitors.
Some of the major players in the antiretroviral therapy market are Gilead, F. Hoffmann-La Roche, ViiV Healthcare, Boehringer Ingelheim, Janssen Pharmaceuticals, Mylan, Abbvie, Bionor Pharma, Vertex Pharmaceuticals, Gilead.
The antiretroviral therapy market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antiretroviral Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antiretroviral Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antiretroviral Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antiretroviral Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antiretroviral Therapy Market Size & Forecast, 2020-2028
4.5.1 Antiretroviral Therapy Market Size and Y-o-Y Growth
4.5.2 Antiretroviral Therapy Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 NNRTIs
5.2.2 NRTI
5.2.3 Multiclass Combination Products
5.2.4 Integrase Inhibitors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antiretroviral Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antiretroviral Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 NNRTIs
9.6.2 NRTI
9.6.3 Multiclass Combination Products
9.6.4 Integrase Inhibitors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 NNRTIs
10.6.2 NRTI
10.6.3 Multiclass Combination Products
10.6.4 Integrase Inhibitors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 NNRTIs
11.6.2 NRTI
11.6.3 Multiclass Combination Products
11.6.4 Integrase Inhibitors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 NNRTIs
12.6.2 NRTI
12.6.3 Multiclass Combination Products
12.6.4 Integrase Inhibitors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 NNRTIs
13.6.2 NRTI
13.6.3 Multiclass Combination Products
13.6.4 Integrase Inhibitors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antiretroviral Therapy Market: Competitive Dashboard
14.2 Global Antiretroviral Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Gilead
14.3.2 F. Hoffmann-La Roche
14.3.3 ViiV Healthcare
14.3.4 Boehringer Ingelheim
14.3.5 Janssen Pharmaceuticals
14.3.6 Mylan
14.3.7 Abbvie
14.3.8 Bionor Pharma
14.3.9 Vertex Pharmaceuticals
14.3.10 Gilead
